You are here

Treatments

Opinion: COVID, flu, RSV: The benefits of advocating for boosters in the workplace–and how to go about it

Fri, 2022-12-09 10:54 — mike kraft

COVID, flu, RSV: The benefits of advocating for boosters in the workplace–and how to go about it The return to the office has turned into a superspreader event. Fortune

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Social behavior

Problem, Solution, SitRep, or ?:

COVID-19 drug Paxlovid has been free; next year, sticker shock awaits

Thu, 2022-12-08 20:11 — mike kraft

COVID-19 drug Paxlovid has been free; next year, sticker shock awaits Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. But the government plans to stop footing the bill within months. UPI

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID-19 drug Paxlovid has been free; next year, sticker shock awaits
Log in or register to post comments

Analysis: Vaccines are key to China’s zero-Covid exit but skepticism poses challenge

Thu, 2022-12-08 12:59 — mike kraft

Vaccines are key to China’s zero-Covid exit but scepticism poses challenge Backing down from existing policies remains a political problem of the first order the Guardian

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Public Attitudes

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Analysis: Vaccines are key to China’s zero-Covid exit but skepticism poses challenge
Log in or register to post comments

COVID spread fears grow as China makes big chnages in zero-tolerance curbs

Thu, 2022-12-08 12:43 — mike kraft

COVID spread fears grow as China unwinds zero-tolerance curbs As many Chinese embraced new freedoms after Beijing dropped parts of its tough COVID regime, concerns mounted that the virus, which had largely been kept in check, could soon run wild. Brenda Goh,Ella Cao Reuters

...

Country / Region Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID spread fears grow as China makes big chnages in zero-tolerance curbs
Log in or register to post comments

Novavax to make COVID-19 vaccine shots in Canada

Thu, 2022-12-08 12:35 — mike kraft

Novavax to make COVID-19 vaccine shots in Canada Novavax Inc said on Wednesday it will manufacture its COVID-19 vaccine in Canada after the country's health regulator allowed its use in children aged between 12 and 17 years as a primary series of shots. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax to make COVID-19 vaccine shots in Canada
Log in or register to post comments

Senate report spotlights systemic problems behind U.S. early COVID response missteps

Thu, 2022-12-08 11:58 — mike kraft

Senate report spotlights systemic problems behind early COVID response missteps The 242-page document is the latest to retrace early U.S. shortcomings to address the SARS-CoV-2 outbreak. CBS News

...

While some of the details are new, the report's authors acknowledge several of their ultimate findings stem from systemic problems known long before President Donald Trump took office.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Senate report spotlights systemic problems behind U.S. early COVID response missteps
Log in or register to post comments

COVID-19 leads to a rise in use of health care services for a variety of 18 conditions long after the acute stage of infection--study.

Thu, 2022-12-08 11:30 — mike kraft

COVID-19’s impact ripples across 18 conditions after initial illness Study of more than 250,000 patients shows rise in use of health care services in the six months following initial acute infection. Learn more. American Medical Association

Country / Region Tags:

General Topic Tags:

Disease Prevention

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old

Thu, 2022-12-08 11:20 — mike kraft

U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old The U.S. Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old
Log in or register to post comments

Estimates of How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization

Wed, 2022-12-07 18:17 — mike kraft

How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization? This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compare… kffmatthewm KFF

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Estimates of How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization
Log in or register to post comments

Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds

Wed, 2022-12-07 13:23 — mike kraft

Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds

Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.

Scientists at the University of Texas Medical Branch, in a study published online Tuesday in Nature Medicine, found that the booster shots performed well against the BA.5 subvariant they were designed to target.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds
Log in or register to post comments

Pages

Page loaded in 0.397 seconds.